Are Your Painkillers Causing Erectile Dysfunction?
Lee Rannals for redOrbit.com – Your Universe Online Feeling a little droopy lately? A new study suggests that it may be due to the prescription painkillers you've been taking. According to a new study published in the journal Spine,...
Latest Ketones Stories
PITTSBURGH, May 17, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has shipped Fenofibrate Tablets, 48 mg and 145 mg. Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is the generic version of Abbvie Inc.'s Tricor(®) Tablets. Fenofibrate Tablets are indicated as adjunctive therapy to diet to reduce...
According to Pure Health Group, opiate Withdrawal is the biggest reason addicts remain addicts in our society and the flu-like symptoms which afflict a person going through withdrawal often cause a person to revert to their addiction and give up on getting clean. Subsequently, the overdose death rates have more than tripled in the last decade; Pure Health Group Inc.™ takes a stand and asks society to spread the word about their solution to prevent these deaths and the painkiller epidemic...
Kaiser Permanente study first to use electronic health records to document link between prescription opioid use and ED prescriptions PORTLAND, Ore., May 15, 2013 /PRNewswire/ -- Regularly taking prescription painkillers, also known as opioids, is associated with a higher risk of erectile dysfunction, according to a study published online today in the journal Spine. The researchers included more than 11,000 men with back pain in the study and examined their health records to...
MALVERN, Pa., May 10, 2013 /PRNewswire/ -- Endo Health Solutions Inc. (Nasdaq: ENDP) announced today that the U.S. Food and Drug Administration (FDA) has denied a Citizen Petition filed by its subsidiary, Endo Pharmaceuticals Inc. Endo presented FDA data collected from an ongoing epidemiology study that indicate that per 100,000 prescriptions dispensed, the past 30-day abuse rate of crush-resistant OPANA ER was 79 percent lower than the abuse rate of generic versions of...
The Coleman Institute was awarded the "Best of the Best" designation for excellence in Florida Addiction by Follow Media Consulting, Inc. Tampa, FL (PRWEB) May 09, 2013 The Coleman Institute was awarded the "Best of the Best" designation for excellence by Follow Media Consulting, Inc. in the category of Florida Addiction. This award signifies the continued commitment and dedication of the areas best in addiction rehabilitation and detoxification programs. The Coleman...
Chief Scientist Participates in Clinical and Basic Science Data Blitz MORAGA, Calif., May 9, 2013 /PRNewswire/ -- Trigemina, Inc., a biopharmaceutical company focused on the discovery and development of non-narcotic, nasally delivered, analgesic drug products, announced that David C. Yeomans, Ph.D., Chief Scientist and Founder, as well as the Director of Pain Research at Stanford University School of Medicine, gave a presentation at the American Pain Society (APS) 32(nd) Annual...
CANTON, Mass., May 8, 2013 /PRNewswire/ -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today announced the presentation of a scientific poster titled "Oxycodone DETERx®, an Extended-release, Abuse-deterrent Formulation for the Management of Chronic Pain," at the American Pain Society's 32(nd) Annual Scientific Meeting, held in New Orleans, Louisiana from May 8(th) to May 10(th). This...
LONDON, May 7, 2013 /PRNewswire/ -- Founder of the drugs charity, Angelus, Maryon Stewart, described the Home Office as "delinquent" in sponsoring a legal high supplier's e-petition. The Home Office have discretion to reject any e-petition under various conditions but chose to sponsor one by UK Skunkworks. The company in question, UK Skunkworks, is the largest supplier of legal psychoactive drugs in southern Britain with 15 shops. It sells products with known harms such...
BRENTWOOD, England, May 3, 2013 /PRNewswire/ -- - World's first licensed naloxone product for use by non-healthcare profession individuals in a community setting - Prenoxad Injection is a pre-filled syringe containing 1mg/ml naloxone hydrochloride solution for injection Martindale Pharma, a leader in the manufacture and supply of specialty pharmaceuticals , is pleased to announce the UK launch of Prenoxad Injection, the world's...
Pivotal data for investigational controlled release misoprostol vaginal insert in the U.S. accepted for presentation NEW ORLEANS, May 2, 2013 /PRNewswire/ -- Ferring Pharmaceuticals will present efficacy and safety data from its Phase 3 EXPEDITE* study for its investigational controlled release misoprostol vaginal insert (MVI) at the 61(st) annual clinical meeting of the American College of Obstetricians and Gynecologists in New Orleans, May 4 - 8, 2013. Studies accepted for...
